Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe – eNCA
eNCA |
Drugmakers' hopes for gene therapy rise despite tiny sales in Europe
eNCA After decades of frustrations, firms believe there are now major opportunities for gene therapy in treating inherited conditions such as haemophilia. They argue that therapies offering one-off cures for intractable diseases will save health providers … |
